Create a free PetfoodIndustry account to continue reading

CBD ‘boom’ brings pet product regulatory issues to light

Established and new pet food companies alike do their best to navigate nebulous legality and regulatory compliance issues, as more players enter the CBD pet products game.

Beaton Headshot New Headshot
Tinnakorn Jorruang | iStockPhoto.com
Tinnakorn Jorruang | iStockPhoto.com

Cannabidiol (CBD) is undeniably experiencing a boom in the pet space, and that boom has created several different challenges for the new segment. Chief among these challenges is the dual struggle to navigate both the nebulous legality of the ingredient and the lack of clear regulation on its use in pet products.

The U.S. government essentially kicked off the CBD frenzy in 2018, when it signed into law the Agriculture Improvement Act of 2018 (otherwise known as the 2018 Farm Bill). The bill removed hemp from the Controlled Substances Act (CSA), which means that cannabis plants and derivatives that contain no more than 0.3% tetrahydrocannabinol (THC, the main psychoactive compound in cannabis) on a dry weight basis are no longer controlled substances under federal law.

However, to muddy the waters, the bill also preserved FDA’s authority to regulate products containing cannabis or cannabis-derived compounds (like CBD) under both the Federal Food, Drug and Cosmetic Act (FD&C Act) and the Public Health Service Act (PHS Act). And according to the agency, “FDA treats products containing cannabis or cannabis-derived compounds as it does any other FDA-regulated products — meaning they’re subject to the same authorities and requirements as FDA-regulated products containing any other substance. This is true regardless of whether the cannabis or cannabis-derived compounds are classified as hemp under the 2018 Farm Bill.”